Cargando…

Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration

The use of cannabidiol (CBD) for treating brain disorders has gained increasing interest. While the mechanism of action of CBD in these conditions is still under investigation, CBD has been shown to affect numerous different drug targets in the brain that are involved in brain disorders. Here we rev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yau, Grace Tsz Yan, Tai, Waiting, Arnold, Jonathon Carl, Chan, Hak-Kim, Kwok, Philip Chi Lip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229467/ https://www.ncbi.nlm.nih.gov/pubmed/36635488 http://dx.doi.org/10.1007/s11095-023-03469-1

Ejemplares similares

Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19
por: Tai, Waiting, et al.
Publicado: (2021)

Therapeutic efficacy of nanoparticles and routes of administration
por: Chenthamara, Dhrisya, et al.
Publicado: (2019)

Plasma Pharmacokinetics of Cannabidiol Following Oral Administration of Cannabidiol Oil to Dairy Calves
por: Meyer, Kelsey, et al.
Publicado: (2022)

Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses
por: Umpierrez, Laísa S., et al.
Publicado: (2022)

The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence
por: Arnold, Jonathon C., et al.
Publicado: (2022)

The therapeutic potential of purified cannabidiol
por: O’Sullivan, Saoirse Elizabeth, et al.
Publicado: (2023)

Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
por: De Ternay, Julia, et al.
Publicado: (2019)

Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
por: Baswan, Sudhir M, et al.
Publicado: (2020)

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021)

Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
por: Pitiot, Aubin, et al.
Publicado: (2022)

Pharmacokinetics of escalating single‐dose administration of cannabidiol to cats
por: Rozental, Aaron J., et al.
Publicado: (2022)

Cannabidiol in Humans—The Quest for Therapeutic Targets
por: Zhornitsky, Simon, et al.
Publicado: (2012)

Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics
por: Nahler, Gerhard
Publicado: (2022)

Cannabidiol-Loaded Nanocarriers and Their Therapeutic Applications
por: Assadpour, Elham, et al.
Publicado: (2023)

The pharmacology and therapeutic role of cannabidiol in diabetes
por: Zhang, Jin, et al.
Publicado: (2023)

ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice
por: Brzozowska, Natalia, et al.
Publicado: (2016)

Delivery Systems and Local Administration Routes for Therapeutic siRNA
por: Vicentini, Fabiana Testa Moura de Carvalho, et al.
Publicado: (2013)

Intranasal delivery: An attractive route for the administration of nucleic acid based therapeutics for CNS disorders
por: Shah, Pranav, et al.
Publicado: (2022)

Cannabidiol as a Novel Therapeutic for Immune Modulation
por: Peyravian, Nadia, et al.
Publicado: (2020)

Oxycodone Self-Administration in Female Rats is Enhanced by ∆(9)-tetrahydrocannabinol, but not by Cannabidiol, in a Progressive Ratio Procedure
por: Nguyen, Jacques D., et al.
Publicado: (2023)

Global brain network dynamics predict therapeutic responsiveness to cannabidiol treatment for refractory epilepsy
por: Anderson, David E, et al.
Publicado: (2020)

Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
por: Campos, Alline C., et al.
Publicado: (2017)

Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice
por: Long, Leonora E., et al.
Publicado: (2012)

Cannabidiol Administration Prevents Hypoxia-Ischemia-Induced Hypomyelination in Newborn Rats
por: Ceprián, María, et al.
Publicado: (2019)

Pharmacokinetics of Cannabidiol Following Intranasal, Intrarectal, and Oral Administration in Healthy Dogs
por: Polidoro, Dakir, et al.
Publicado: (2022)

Pharmacokinetics of cannabidiol following single oral and oral transmucosal administration in dogs
por: della Rocca, Giorgia, et al.
Publicado: (2023)

Phage–Antibiotic Therapy as a Promising Strategy to Combat Multidrug-Resistant Infections and to Enhance Antimicrobial Efficiency
por: Liu, Chengxi, et al.
Publicado: (2022)

Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
por: Anderson, Lyndsey L., et al.
Publicado: (2019)

Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations
por: Anderson, Lyndsey L., et al.
Publicado: (2021)

Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke
por: Hayakawa, Kazuhide, et al.
Publicado: (2010)

Cannabidiol and Neurodevelopmental Disorders in Children
por: Kwan Cheung, Keith A., et al.
Publicado: (2021)

The Pro-neurogenic Effects of Cannabidiol and Its Potential Therapeutic Implications in Psychiatric Disorders
por: Luján, Miguel Á., et al.
Publicado: (2020)

Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
por: Singh, Kuldeep, et al.
Publicado: (2023)

Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy
por: Shao, Zitong, et al.
Publicado: (2021)

Pulmonary route of administration is instrumental in developing therapeutic interventions against respiratory diseases
por: Jin, Xue, et al.
Publicado: (2020)

HALOPERIDOL DECANOATE : ROUTE OF ADMINISTRATION
por: Andrade, Chittaranjan
Publicado: (1998)

Topical Administration of Cannabidiol: Influence of Vehicle-Related Aspects on Skin Permeation Process
por: Casiraghi, Antonella, et al.
Publicado: (2020)

Effects of cannabidiol on weight and fasting blood sugar with chronic and subchronic haloperidol administration
por: Kajero, Jaiyeola Abiola, et al.
Publicado: (2022)

Acceptability of cannabidiol in patients with psychosis
por: Chesney, Edward, et al.
Publicado: (2022)

Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury
por: Martínez-Orgado, José, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l6t5oclmnd64l46jtv8gl592ma